Stock Track | ANGELALIGN Soars 5.40% Intraday on MDR-CE Certification for EU Market Access

Stock Track
01/08

ANGELALIGN (06699) surged 5.40% during Thursday's intraday session, reflecting strong investor optimism following the company's recent regulatory milestone.

The clear aligner specialist obtained the MDR-CE certificate from TÜV SÜD, confirming its products meet the EU's stringent Medical Device Regulation requirements. This certification marks a critical step in ANGELALIGN's international expansion, as it enables access to high-standard European markets and enhances the company's global credibility.

CEO Hu Jiezhang highlighted that international cases now represent over 50% of total case volume, with operations spanning 60+ countries. The MDR-CE certification is expected to further strengthen ANGELALIGN's competitive position in the global clear aligner market.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10